M.C. Jung
- Hepatology top 2%
- Epidemiology top 10%
- Immunology
- Rheumatology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- G. R. PapeHelmut M. DiepolderRoman ZachovalRobert M. HoffmannE A WierengaJ. Tilman GerlachS. ScholzTeresa Santantonio
- Topics
- Hepatitis C virus research (11 papers)Hepatitis B Virus Studies (7 papers)Liver Disease Diagnosis and Treatment (3 papers)
- Cited by
- HepatologyVirologyEpidemiology
- Partner nations
- GermanySouth KoreaAustralia
In The Last Decade
M.C. Jung
15 papers receiving 522 citations
Peers
Comparison fields: 5 of 50
- Hepatology 435
- Epidemiology 333
- Immunology 165
- Rheumatology 69
- Radiology, Nuclear Medicine and Imaging 66
Countries citing papers authored by M.C. Jung
This map shows the geographic impact of M.C. Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Jung more than expected).
Fields of papers citing papers by M.C. Jung
This network shows the impact of papers produced by M.C. Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Jung. The network helps show where M.C. Jung may publish in the future.
Co-authorship network of co-authors of M.C. Jung
This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Jung. A scholar is included among the top collaborators of M.C. Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Jung. M.C. Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 23 | |
| 6 | 10 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 29 | |
| 10 | Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C. | 13 |
| 11 | 14 | |
| 12 | 261 | |
| 13 | 87 | |
| 14 | 32 | |
| 15 | 26 | |
| 16 | 4 | |
| 17 | 15 | |
| 18 | 17 |
About M.C. Jung
M.C. Jung is a scholar working on Hepatology, Transplantation and Epidemiology, having authored 18 papers that have together received 539 indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (435 citations), Virology (58 citations) and Epidemiology (333 citations). M.C. Jung has collaborated with scholars based in Germany, South Korea and Australia. Frequent co-authors include G. R. Pape, Helmut M. Diepolder, Roman Zachoval, Robert M. Hoffmann, E A Wierenga, J. Tilman Gerlach, S. Scholz, Teresa Santantonio, Michael Houghton and Scott Southwood. Their work appears in journals such as The Journal of Immunology, Journal of Virology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.